268 related articles for article (PubMed ID: 31177386)
21. CCR2-V64I polymorphism is associated with increased risk of cervical cancer but not with HPV infection or pre-cancerous lesions in African women.
Chatterjee K; Dandara C; Hoffman M; Williamson AL
BMC Cancer; 2010 Jun; 10():278. PubMed ID: 20537184
[TBL] [Abstract][Full Text] [Related]
22. Single nucleotide polymorphisms in the DNA repair genes in HPV-positive cervical cancer.
Bajpai D; Banerjee A; Pathak S; Thakur B; Jain SK; Singh N
Eur J Cancer Prev; 2016 May; 25(3):224-31. PubMed ID: 25812040
[TBL] [Abstract][Full Text] [Related]
23. Influence of IL-6, IL-8, and TGF-β1 gene polymorphisms on the risk of human papillomavirus-infection in women from Pernambuco, Brazil.
Lima SF; Tavares MM; Macedo JL; Oliveira RS; Heráclio SA; Maia MM; Souza PR; Moura R; Crovella S
Mem Inst Oswaldo Cruz; 2016 Nov; 111(11):663-669. PubMed ID: 27783717
[TBL] [Abstract][Full Text] [Related]
24. Human papillomavirus genotype distribution and cervical squamous intraepithelial lesions among high-risk women with and without HIV-1 infection in Burkina Faso.
Didelot-Rousseau MN; Nagot N; Costes-Martineau V; Vallès X; Ouedraogo A; Konate I; Weiss HA; Van de Perre P; Mayaud P; Segondy M;
Br J Cancer; 2006 Aug; 95(3):355-62. PubMed ID: 16832413
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the association of NKG2C copy number variations with susceptibility to human papillomavirus-induced cervical lesions.
Vilchez JR; Torres-Moreno D; Martínez-Senac MM; Trujillo-Santos J; Conesa-Zamora P
Hum Immunol; 2013 Oct; 74(10):1352-6. PubMed ID: 23911737
[TBL] [Abstract][Full Text] [Related]
26. Contribution of HLA-G and FOXP3 genes and proteins in the severity of cervical intraepithelial neoplasia during HPV infection.
da Silva NCH; Sonon P; Medeiros FS; da Silva MC; Dos Santos Gomes FO; Peixoto CA; Crispim JCO; Paiva LA; Rygaard MCV; Menezes MLB; Welkovic S; Donadi EA; Lucena-Silva N
Hum Immunol; 2023 Aug; 84(8):408-417. PubMed ID: 37149423
[TBL] [Abstract][Full Text] [Related]
27. Genetic variants of the dUTPase-encoding gene DUT increase HR-HPV infection rate and cervical squamous cell carcinoma risk.
Ye F; Wang H; Liu J; Cheng Q; Chen X; Chen H
Sci Rep; 2019 Jan; 9(1):513. PubMed ID: 30679536
[TBL] [Abstract][Full Text] [Related]
28. HPV RNA in situ hybridization can inform cervical cytology-histology correlation.
Coppock JD; Willis BC; Stoler MH; Mills AM
Cancer Cytopathol; 2018 Aug; 126(8):533-540. PubMed ID: 29975461
[TBL] [Abstract][Full Text] [Related]
29. Genome-wide association study of prevalent and persistent cervical high-risk human papillomavirus (HPV) infection.
Adebamowo SN; Adeyemo AA; Rotimi CN; Olaniyan O; Offiong R; Adebamowo CA;
BMC Med Genet; 2020 Nov; 21(1):231. PubMed ID: 33225922
[TBL] [Abstract][Full Text] [Related]
30. Persistent high-risk human papillomavirus infections and other end-point markers of progressive cervical disease among women prospectively followed up in the New Independent States of the Former Soviet Union and the Latin American Screening study cohorts.
Syrjänen K; Shabalova I; Naud P; Kozachenko V; Derchain S; Zakharchenko S; Roteli-Martins C; Nerovjna R; Longatto-Filho A; Kljukina L; Tatti S; Branovskaja M; Hammes LS; Branca M; Grunjberga V; Erzen M; Sarian LO; Juschenko A; Costa S; Podistov J; Syrjänen S;
Int J Gynecol Cancer; 2009 Jul; 19(5):934-42. PubMed ID: 19574788
[TBL] [Abstract][Full Text] [Related]
31. Genetic association study of intron variants in the forkhead box protein P3 gene in Chinese patients diagnosed with cervical cancer.
Shi F; Pang XX; Li GJ; Chen ZH; Dong MY; Wang JL
J Cell Mol Med; 2022 May; 26(9):2658-2672. PubMed ID: 35322929
[TBL] [Abstract][Full Text] [Related]
32. Value of HPV 16/18 Genotyping and p16/Ki-67 Dual Staining to Predict Progression to HSIL/CIN2+ in Negative Cytologies From a Colposcopy Referral Population.
Rodríguez-Trujillo A; Martí C; Angeles MA; Sierra A; Esteve R; Saco A; Barnadas E; Marimón L; Nicolás I; Torné A; Ordi J; Del Pino M
Am J Clin Pathol; 2018 Oct; 150(5):432-440. PubMed ID: 30052715
[TBL] [Abstract][Full Text] [Related]
33. Screening for persistent high-risk HPV infections may be a valuable screening method for young women; A retrospective cohort study.
Ebisch RMF; Ketelaars PJW; van der Sanden WMH; Schmeink CE; Lenselink CH; Siebers AG; Massuger LFAG; Melchers WJG; Bekkers RLM
PLoS One; 2018; 13(10):e0206219. PubMed ID: 30356297
[TBL] [Abstract][Full Text] [Related]
34. Significant association between IL10-1082/-819 and TNF-308 haplotypes and the susceptibility to cervical carcinogenesis in women infected by Human papillomavirus.
Chagas BS; Lima RCP; Paiva Júnior SSL; Silva RCO; Cordeiro MN; Silva Neto JDC; Batista MVA; Silva AJD; Gurgel APAD; Freitas AC
Cytokine; 2019 Jan; 113():99-104. PubMed ID: 29935877
[TBL] [Abstract][Full Text] [Related]
35. Triage of LSIL/ASC-US with p16/Ki-67 dual staining and human papillomavirus testing: a 2-year prospective study.
White C; Bakhiet S; Bates M; Keegan H; Pilkington L; Ruttle C; Sharp L; O' Toole S; Fitzpatrick M; Flannelly G; O' Leary JJ; Martin CM
Cytopathology; 2016 Aug; 27(4):269-76. PubMed ID: 26932360
[TBL] [Abstract][Full Text] [Related]
36. Application of human papillomavirus in screening for cervical cancer and precancerous lesions.
Wang JL; Yang YZ; Dong WW; Sun J; Tao HT; Li RX; Hu Y
Asian Pac J Cancer Prev; 2013; 14(5):2979-82. PubMed ID: 23803065
[TBL] [Abstract][Full Text] [Related]
37. HPV detection rates and histopathologic follow-up of patients with HSIL cytology in a large academic women's hospital laboratory.
Ashman D; Zhang H; Li J; Austin M; Wang T; Pradhan D; Zhao C
J Am Soc Cytopathol; 2020; 9(6):550-555. PubMed ID: 32475726
[TBL] [Abstract][Full Text] [Related]
38. Performance of Aptima and Cobas HPV testing platforms in detecting high-grade cervical dysplasia and cancer.
Ge Y; Christensen P; Luna E; Armylagos D; Schwartz MR; Mody DR
Cancer Cytopathol; 2017 Aug; 125(8):652-657. PubMed ID: 28574670
[TBL] [Abstract][Full Text] [Related]
39. Association between p21 Ser31Arg polymorphism and the development of cervical lesion in women infected with high risk HPV.
Lima G; Santos E; Angelo H; Oliveira M; Heráclio S; Leite F; de Melo C; Crovella S; Maia M; Souza P
Tumour Biol; 2016 Aug; 37(8):10935-41. PubMed ID: 26886286
[TBL] [Abstract][Full Text] [Related]
40. HLA DOA1 and DOB1 loci in Honduran women with cervical dysplasia and invasive cervical carcinoma and their relationship to human papillomavirus infection.
Ferrera A; Olivo A; Alaez C; Melchers WJ; Gorodezky C
Hum Biol; 1999 Jun; 71(3):367-79. PubMed ID: 10380373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
